HRT Financial’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.31M Buy
1,235,153
+686,722
+125% +$2.47M 0.01% 1096
2025
Q4
$1.88M Buy
548,431
+111,856
+26% +$499K 0.01% 1346
2025
Q3
$2.19M Buy
436,575
+65,562
+18% +$289K 0.01% 1093
2025
Q2
$1.27M Buy
371,013
+177,730
+92% +$442K 0.01% 1141
2025
Q1
$431K Sell
193,283
-56,943
-23% -$163K ﹤0.01% 1546
2024
Q4
$733K Buy
250,226
+120,322
+93% +$335K ﹤0.01% 1248
2024
Q3
$337K Buy
+129,904
New +$360K ﹤0.01% 1757
2024
Q1
Sell
-90,562
Closed -$517K 2204
2023
Q4
$517K Buy
90,562
+28,361
+46% +$131K ﹤0.01% 1343
2023
Q3
$286K Sell
62,201
-67,011
-52% -$408K ﹤0.01% 1682
2023
Q2
$834K Sell
129,212
-427,062
-77% -$2.91M 0.01% 1053
2023
Q1
$4.19M Buy
+556,274
New +$5.05M 0.05% 300
2022
Q2
Sell
-62,568
Closed -$610K 2840
2022
Q1
$610K Buy
+62,568
New +$592K ﹤0.01% 1492
2021
Q2
Sell
-27,366
Closed -$929K 2762
2021
Q1
$929K Buy
+27,366
New +$1.09M 0.01% 1236

Other funds holding ABCL